Abstracts

Citation

Katherine Luzuriaga, M.D., Margaret McManus, B.S., Shane Mayack, Mark Sharkey, John L. Sullivan, M.D. Evidence For Cessation Of Viral Replication and Absence Of Virus-Specific Immunity.

Citation

Ellen Gould Chadwick, M.D., John H. Rodman, Pharm.D., Pearl Samson, M.S., Leslie A. Petch, Ph.D., Susan A. Fiscus, Ph.D., Terence Fenton, Ed.D., Elaine J. Abrams, M.D., Holly Meyers, B.S., Charles Rose, Ram Yogev, M.D. Evolution of Genotypic Resistance and Pharmacokinetic Measures of Adherence in Children Failing Ritonavir/Indinavir (RTV/IDV) Combination Regimens.

Citation

Cindy Vavro, Paul Palumbo, Andrew Wiznia, Carmelita Alvero, Bobbie Graham, Terry Fenton, Rohan Hazra, Ellen O’Gara, Ann M Buchanan, Joe Horton, Rolando M Viani. Evolution of HIV-1 Integrase Following Selection of R263K with Further Dolutegravir Treatment; A Case Report from the P1093 study. Presented at: IAS 2015.

Citation

Ross E. McKinney, Jr., M.D., John H. Rodman, Pharm.D., Mobeen H. Rathore, M.D., ChengCheng Hu, Ph.D., Patricia M. Flynn, M.D., M.S., Michael Hughes, Ph.D., Ruth E. Dickover, Ph.D., Adriana Weinberg, M.D., M. Robert Blum, Ph.D., David Sahner, M.D., Shirley Jankelevich, M.D., Leslie Serchuck, M.D., Alberto A. Ortiz, M.S., Paul T. Tran, R.Ph. Extended Followup and Pharmacokinetics for Once Daily Emtricitabine, Didanosine, and Efavirenz for Antiretroviral Naive Children and Adolescents.

Citation

C Onyango-Makumbi, RS Mwiru, AH Owora, A Mwatha, AM Young, D Moodley, HM Coovadia, L Stranix-Chibanda, K Manji, Y Maldonado, P Richardson, P Andrew, K George, W Fawzi, MG Fowler. Extended prophylaxis with nevirapine does not affect growth in HIV-exposed infants. Presented at: CROI 2019; 2019 Mar 07.

Citation

Coleen K. Cunningham, Edmund V. Capparelli, Elizabeth J. McFarland, Petronella Muresan, Charlotte Perlowski, Dwight Yin, Jack Moye, Sai Majji, Lynette Purdue, Paul A. Harding, Adrian McDermott, John R. Mascola, Barney S. Graham, IMPAACT P1112 team. Extended Safety and PK and Anti-HIV Monoclonal AB VRC07-523LS in HIV-exposed Infants. Presented at: CROI 2022; 2022 Feb 16.

Citation

Factors Associated with Lack of Viral Suppression at Delivery in the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025.

Citation

Adriana Weinberg, M.D., Sharon Huang, M.S., Terence Fenton, Ed.D., Julie A. Patterson, B.S., Philimon Gona, Ph.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Wayne M. Dankner, M.D., Sharon Appelbaum Nachman, M.D. Factors Associated with Robust Antibody Responses to the Hepatitis A Virus (HAV) Vaccine in HIV-Infected Children: IMPAACT P1008. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Petina Musara, Lynda Stranix-Chibanda, Peter Slutzker, Juliane Etima, Rebecca Nabukenya, Florence Mathebula, Linly Seyama, Mary Nyasha Tichareva, Otilia Munaiwa, Tambudzai Mutasa, Emily Brown, Hans M.L. Spiegel, Deborah Kacanek, Benjamin Chi, K. Rivet Amico, IMPAACT 2009 Study Team. Factors influencing adherence to daily oral PrEP during pregnancy and postpartum: Qualitative findings from Malawi, South Africa, Uganda and Zimbabwe. Presented at: IAS 2025; 2025 Jul 15.

Citation

S Kim, A Gupta, X Wu, M Hughes, R Dawson, V Mave, N Kumarasamy, B Smith, R Rustomgee, NS Shah, A Hesseling, S Swindells, G Churchyard, ACTG/IMPAACT A5300/I2003 PHOENIx Feasibility Study team. Factors Related to TB Infection in MDR-TB Household contact >15 Years Old. Presented at: CROI 2020.